Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.71 |
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.71 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.71 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.57 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.57 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.56 |
| ▸ | PPARG | P37231 | 7/20 | 0.55 |
| ▸ | PPARD | Q03181 | 7/20 | 0.55 |
| ▸ | PPARA | Q07869 | 7/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.55 |
| ▸ | TLR2 | O60603 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | FABP4 | P15090 | 2/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4534190 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL4528754 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL401025 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL4530530 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL6887374 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL4525726 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL4520218 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL4518788 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL4529944 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL4523441 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119798537-A | Biosensor, biosensor outer film, and preparation method and application of biosensor outer film | 上海微创生命科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119680635-A | Ionic liquid catalyst for producing renewable fuel from waste grease and preparation method and application thereof | 中国科学院青岛生物能源与过程研究所 | 2025-03-25 | — | — | CN | claimed |
| CN-118221674-B | Pyrrolo [3,2-b ] pyridine Top/HDAC double-target inhibitor, preparation method, pharmaceutical composition and application thereof | 南京市鸿舜医药科技有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-118724984-A | Adsorption type film-forming corrosion inhibitor with high stability and preparation method thereof | 江苏创新石化有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-118576709-A | Photosensitive carrier and preparation method and application thereof | 大连理工大学 | 2024-09-03 | — | — | CN | claimed |
| CN-118221674-A | Pyrrolo [3,2-b ] pyridine Top/HDAC double-target inhibitor, preparation method, pharmaceutical composition and application thereof | 南京市鸿舜医药科技有限公司 | 2024-06-21 | — | — | CN | claimed |
| US-20240140898-A1 | METHOD FOR MAKING OMEGA BROMOALKANOIC ACIDS AND ESTERS | ARKEMA FRANCE (FR) | 2024-05-02 | — | — | US | claimed |
| US-20240116961-A1 | TRIPHENYPHOSPHINE MODIFIED SERTRALINE DERIVATIVE AND METHODS THEREOF | XIAMEN UNIVERSITY (CN) | 2024-04-11 | — | — | US | claimed |
| CN-117800958-A | Preparation method and application of aggregation-induced emission nano-particles | 贵州医科大学 | 2024-04-02 | — | — | CN | claimed |
| CN-117751938-A | Nano container loaded with anti-fouling agent and anti-fouling paint composition | 浙江鱼童新材料股份有限公司 | 2024-03-26 | — | — | CN | claimed |
| WO-2023165558-A1 | TRIPHENYLPHOSPHINE-MODIFIED SERTRALINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 厦门大学 | 2023-09-07 | — | — | WO | claimed |
| EP-4178939-A1 | METHOD FOR MAKING OMEGA BROMOALKANOIC ACIDS AND ESTERS | ARKEMA FRANCE (FR) | 2023-05-17 | — | — | EP | claimed |
| CN-115803312-A | Process for the preparation of omega-bromoalkanoic acids and esters | 阿科玛法国公司 | 2023-03-14 | — | — | CN | claimed |
| CN-114716475-A | Triphenylphosphine modified sertraline derivative and preparation method and application thereof | 厦门大学 | 2022-07-08 | — | — | CN | claimed |
| CN-113040145-B | Preparation method of elm spot moth sex attractant | 虫捕头(苏州)生物科技有限公司 | 2022-04-08 | — | — | CN | claimed |
| CN-104478755-A | Preparation method of polymerizable zwitterionic surfactant | UNIV LIAONING SHIHUA | 2015-04-01 | — | — | CN | claimed |
| CN-122080068-A | Mitochondria-targeted lonidamine and cinnamaldehyde coupled prodrug as well as preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260116844-A1 | LIPID NANOPARTICLE FORMULATION COMPRISING IONIZED LIPIDS WITH BRANCHED STRUCTURE, AND USE THEREOF | SurgiNex Co., Ltd. (KR) | 2026-04-30 | — | — | US | disclosed |
| US-3969384-A | Esters of cyclopropane alkanoic acids | ZOECON CORPORATION (US) | 1976-07-13 | — | — | US | disclosed |
| US-3960907-A | MITICIDES | ZOECON CORPORATION (US) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116961-A1 | TRIPHENYPHOSPHINE MODIFIED SERTRALINE DERIVATIVE AND METHODS THEREOF | PINK1, TPH1, HTR5A | TSHR 1175/4885LMNA 1713/4885NFKB1 3672/4885 |
| US-20260116844-A1 | LIPID NANOPARTICLE FORMULATION COMPRISING IONIZED LIPIDS WITH BRANCHED STRUCTURE, AND USE THEREOF | NPC1L1, NPC1, STARD3 | TSHR 1621/4885LMNA 596/4885NFKB1 1955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.